Skip to content

Application of new magnetic resonance sequences in renal tumors

Application of new magnetic resonance sequences in renal tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400091707
Enrollment
Unknown
Registered
2024-11-01
Start date
2024-11-03
Completion date
Unknown
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney tumor

Interventions

Kidney cancer patient group:None

Sponsors

Yantai Yuhuangding Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Patients with renal tumors confirmed by CT

Exclusion criteria

Exclusion criteria: 1. Patients with severe acute complications or unstable condition. 2. Other primary malignancies within the past five years. 3. Patients who are unable to cooperate with the completion of MRI examination due to cognitive impairment, mental illness, etc. 4. Patients with metal implants or other contraindications to MRI in the body. 5. The tumor has been surgically removed 6.Patients who have not signed the informed consent form

Design outcomes

Primary

MeasureTime frame
New sequence parameters for magnetic resonance;

Countries

China

Contacts

Public ContactHeng Ma

Yantai Yuhuangding Hospital

mhyhd@163.com+86 159 0891 5896

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026